Entrada Therapeutics Inc (TRDA)
Stock-Based Compensation
$5.15M
Quarterly · Period ending: · USD
TRDA Stock-Based Compensation
Latest reported$5.15Mperiod ending
Latest reported$5.15Mperiod ending
TRDA Quarterly Stock-Based Comp ($76.00K → $5.15M)
Quarterly stock-based compensation
High-resolution chart · PNG
TRDA stock-based compensation history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Stock-Based Compensation (USD) |
|---|---|
| 5,150,000 | |
| 4,744,000 | |
| 4,358,000 | |
| 5,116,000 | |
| 5,048,000 | |
| 5,087,000 | |
| 4,700,000 | |
| 4,860,000 | |
| 4,622,000 | |
| 3,733,000 | |
| 3,841,000 | |
| 3,396,000 | |
| 3,119,000 | |
| 2,755,000 | |
| 2,882,000 | |
| 2,707,000 | |
| 2,512,000 | |
| 1,794,000 | |
| 1,458,000 | |
| 578,000 | |
| 326,000 | |
| 164,000 | |
| 98,000 | |
| 75,000 | |
| 76,000 | |
| 76,000 |